Emami Ltd Q1 FY26 Earnings Analysis

Published 4 Aug 2026 | Personal Products | Market Cap: ₹19.4K Cr

Price

406

Market Cap

₹19.4K Cr

P/E Ratio

24.1

Earnings Summary

- Emami expects strong performance across the board in FY ‘26, with market shares and household penetration trending upwards. - Emami Limited is optimistic about strong all-round growth in FY ‘26 driven by market share gains and household penetration improvements.

📊 Revenue & Sales Performance

- Emami expects strong performance across the board in FY ‘26, with market shares and household penetration trending upwards. - Optimistic about growth in male grooming (Smart and Handsome), Kesh King, and The Man Company due to strategic actions and new leadership. - Anticipates gradual consumption pickup supported by easing inflation, higher disposable income, government CAPEX, accommodative monetary policy, and potential rate cuts. - Organized channels (modern trade, e-commerce, institutional sales) growing faster than overall domestic business, indicating further growth potential. - International business showing promising rebound with growth in SAARC, Southeast Asia, CIS, and Africa regions. - New product development (NPD) momentum to continue, with over 25 new products launched in FY ‘25 and plans for more in FY ‘26. - Targeting strong double-digit growth in The Man Company and Brillare brands in FY ‘26. - Price growth expected at around 2%-3% for FY ‘26.

📈 Profitability & Margins

- Emami Limited is optimistic about strong all-round growth in FY ‘26 driven by market share gains and household penetration improvements. - Strategic actions for male grooming, Kesh King, and The Man Company are expected to generate positive momentum. - International business and strategic investments show promising signs of rebound supporting growth. - FY ‘26 pricing growth is expected to be in the range of 2% to 3%, similar to previous years. - Gross margins remain stable with no significant pressure anticipated; slight cost benefits from benign crude and packaging prices. - Healthcare business targets higher returns via improved marketing and leveraging new product launches. - New leadership at The Man Company aims for fast-tracked growth and long-term profitability. - Overall, sustained volume growth, controlled costs, and focused innovations underpin expectations of robust earnings, operating profits, and EPS growth in FY ‘26.

🏗️ Capital Expenditure Plans

- The transcript does not explicitly mention any specific current or future capex or strategic investment amounts. - However, management expressed optimism about growth driven by easing inflation, tax benefits, and accommodative monetary policy, which may support capital investment activities. - They emphasized strategic actions for male grooming, Kesh King, and The Man Company focused on growth and profitability. - International business and strategic investments are showing promising signs of rebound, indicating continued focus on expanding these areas. - There is significant investment in building brand franchises for The Man Company and Brillare, targeting high double-digit growth. - New product development (NPD), especially in healthcare and D2C segments like Zanducare, continues with over 25 new product launches in FY ‘25. - Overall, investment efforts are focused on advertising (Rs. 690+ crore spent in FY ‘25) and brand building rather than specific capex projects.

💰 Fundraising & Capital Structure

- There is no mention of any current or planned fundraising through debt or equity in the provided transcript. - The management did not discuss any plans related to raising capital via new debt or equity issuances during the Q4 FY '25 earnings call. - The focus was primarily on business growth strategies, brand relaunches, innovation, and operational performance. - Dividend payouts were highlighted, with a total dividend of 1000% or Rs. 10 per share declared for FY '25, indicating cash returns to shareholders rather than raising external capital.

📋 Order Book & Pipeline

The transcript provided does not contain any information regarding the current or expected order book or pending orders for Emami Limited. The discussion primarily focuses on financial results, business performance, product launches, marketing strategies, and growth outlooks for FY ’25 and FY ’26, without mention of order books or pending orders.

Key Metrics

Frequently Asked Questions

What were Emami Ltd Q1 FY26 results?

- Emami expects strong performance across the board in FY ‘26, with market shares and household penetration trending upwards. - Emami Limited is optimistic about strong all-round growth in FY ‘26 driven by market share gains and household penetration improvements.

What is Emami Ltd share price analysis?

Emami Ltd currently shows a neutral. The stock trades at a P/E of 24.1 with a market cap of ₹19,402. Investors should review the full earnings analysis for detailed insights.

Is Emami Ltd planning capital expenditure?

- The transcript does not explicitly mention any specific current or future capex or strategic investment amounts. - However, management expressed optimism about growth driven by easing inflation, tax benefits, and accommodative monetary policy, which may support capital investment activities. - They emphasized strategic actions for male grooming, Kesh King, and The Man Company focused on growth and profitability. - International business and strategic investments are showing promising signs of rebound, indicating continued focus on expanding these areas. - There is significant investment in building brand franchises for The Man Company and Brillare, targeting high double-digit growth. - New product development (NPD), especially in healthcare and D2C segments like Zanducare, continues with over 25 new product launches in FY ‘25. - Overall, investment efforts are focused on advertising (Rs.

This analysis is AI-generated based on publicly available earnings data and concall transcripts. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.

Others in Personal Products this season

  • Dabur India Ltd (Q1 FY26)

    Dabur India Ltd Q1 FY26 quarterly results analysis. No information is provided regarding the same in the latest conference call. Market Cap ₹82,955, P/E 43.5. A

  • Bajaj Consumer Care Ltd (Q1 FY26)

    Bajaj Consumer Care Ltd Q1 FY26 quarterly results analysis. No information is provided regarding the same in the latest conference call. Market Cap ₹7,020, P/E

  • Colgate-Palmolive (India) Ltd (Q1 FY26)

    Colgate-Palmolive (India) Ltd Q1 FY26 quarterly results analysis. - Volume growth was flat in the last quarter, with slightly negative pricing contributing to i